These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10340555)

  • 101. A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].
    Patel P; Young JG; Mautner V; Ashdown D; Bonney S; Pineda RG; Collins SI; Searle PF; Hull D; Peers E; Chester J; Wallace DM; Doherty A; Leung H; Young LS; James ND
    Mol Ther; 2009 Jul; 17(7):1292-9. PubMed ID: 19367257
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer.
    Kim KH; Dmitriev I; O'Malley JP; Wang M; Saddekni S; You Z; Preuss MA; Harris RD; Aurigemma R; Siegal GP; Zinn KR; Curiel DT; Alvarez RD
    Clin Cancer Res; 2012 Jun; 18(12):3440-51. PubMed ID: 22510347
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Osteocalcin-directed gene therapy for prostate-cancer bone metastasis.
    Koeneman KS; Kao C; Ko SC; Yang L; Wada Y; Kallmes DF; Gillenwater JY; Zhau HE; Chung LW; Gardner TA
    World J Urol; 2000 Apr; 18(2):102-10. PubMed ID: 10854144
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up.
    Hasenburg A; Tong XW; Fischer DC; Rojas-Martinez A; Nyberg-Hoffman C; Kaplan AL; Kaufman RH; Ramzy I; Aguilar-Cordova E; Kieback DG
    Gynecol Oncol; 2001 Dec; 83(3):549-54. PubMed ID: 11733970
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer.
    Hasenburg A; Fischer DC; Tong XW; Rojas-Martinez A; Nyberg-Hoffman C; Orlowska-Volk M; Kohlberger P; Kaufman RH; Ramzy I; Aguilar-Cordova E; Kieback DG
    Int J Gynecol Cancer; 2002; 12(1):66-73. PubMed ID: 11860538
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.
    Aguilar LK; Shirley LA; Chung VM; Marsh CL; Walker J; Coyle W; Marx H; Bekaii-Saab T; Lesinski GB; Swanson B; Sanchez D; Manzanera AG; Aguilar-Cordova E; Bloomston M
    Cancer Immunol Immunother; 2015 Jun; 64(6):727-36. PubMed ID: 25795132
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity.
    Predina JD; Haas AR; Martinez M; O'Brien S; Moon EK; Woodruff P; Stadanlick J; Corbett C; Frenzel-Sulyok L; Bryski MG; Eruslanov E; Deshpande C; Langer C; Aguilar LK; Guzik BW; Manzanera AG; Aguilar-Cordova E; Singhal S; Albelda SM
    Mol Ther; 2021 Feb; 29(2):658-670. PubMed ID: 33160076
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer.
    Freytag SO; Movsas B; Aref I; Stricker H; Peabody J; Pegg J; Zhang Y; Barton KN; Brown SL; Lu M; Savera A; Kim JH
    Mol Ther; 2007 May; 15(5):1016-23. PubMed ID: 17375076
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial).
    Lu M; Freytag SO; Stricker H; Kim JH; Barton K; Movsas B
    Contemp Clin Trials; 2011 May; 32(3):453-60. PubMed ID: 21300181
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma.
    Kieran MW; Goumnerova L; Manley P; Chi SN; Marcus KJ; Manzanera AG; Polanco MLS; Guzik BW; Aguilar-Cordova E; Diaz-Montero CM; DiPatri AJ; Tomita T; Lulla R; Greenspan L; Aguilar LK; Goldman S
    Neuro Oncol; 2019 Mar; 21(4):537-546. PubMed ID: 30883662
    [TBL] [Abstract][Full Text] [Related]  

  • 111. GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy.
    Sonpavde G; Thompson TC; Jain RK; Ayala GE; Kurosaka S; Edamura K; Tabata K; Ren C; Goltsov AA; Mims MP; Hayes TG; Ittmann MM; Wheeler TM; Gee A; Miles BJ; Kadmon D
    Clin Cancer Res; 2011 Nov; 17(22):7174-82. PubMed ID: 21933889
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology.
    Belldegrun A; Tso CL; Zisman A; Naitoh J; Said J; Pantuck AJ; Hinkel A; deKernion J; Figlin R
    Hum Gene Ther; 2001 May; 12(8):883-92. PubMed ID: 11387054
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Silk-elastin-like hydrogel improves the safety of adenovirus-mediated gene-directed enzyme-prodrug therapy.
    Gustafson JA; Price RA; Greish K; Cappello J; Ghandehari H
    Mol Pharm; 2010 Aug; 7(4):1050-6. PubMed ID: 20586469
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Dosimetric and technical considerations for interstitial adenoviral gene therapy as applied to prostate cancer.
    Li S; Simons J; Detorie N; O'Rourke B; Hamper U; DeWeese TL
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):204-14. PubMed ID: 12504055
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model.
    VanderVeen N; Raja N; Yi E; Appelman H; Ng P; Palmer D; Zamler D; Dzaman M; Lowenstein PR; Castro MG
    Hum Gene Ther Methods; 2016 Jun; 27(3):98-111. PubMed ID: 27056322
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer.
    Freytag SO; Stricker H; Peabody J; Pegg J; Paielli D; Movsas B; Barton KN; Brown SL; Lu M; Kim JH
    Mol Ther; 2007 Mar; 15(3):636-42. PubMed ID: 17228316
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
    Nyati S; Stricker H; Barton KN; Li P; Elshaikh M; Ali H; Brown SL; Hwang C; Peabody J; Freytag SO; Movsas B; Siddiqui F
    PLoS One; 2023; 18(9):e0291315. PubMed ID: 37713401
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer.
    Teh BS; Aguilar-Cordova E; Vlachaki MT; Aguilar L; Mai WY; Caillouet J; Davis M; Miles B; Kadmon D; Ayala G; Lu HH; Chiu JK; Carpenter LS; Woo SY; Grant WH; Wheeler T; Thompson TC; Butler EB
    Oncologist; 2002; 7(5):458-66. PubMed ID: 12401909
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.
    Matthews K; Noker PE; Tian B; Grimes SD; Fulton R; Schweikart K; Harris R; Aurigemma R; Wang M; Barnes MN; Siegal GP; Hemminki A; Zinn K; Curiel DT; Alvarez RD
    Clin Cancer Res; 2009 Jun; 15(12):4131-7. PubMed ID: 19509153
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.
    Aggarwal C; Haas AR; Metzger S; Aguilar LK; Aguilar-Cordova E; Manzanera AG; Gómez-Hernández G; Katz SI; Alley EW; Evans TL; Bauml JM; Cohen RB; Langer CJ; Albelda SM; Sterman DH
    Mol Ther; 2018 May; 26(5):1198-1205. PubMed ID: 29550074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.